Clinical observation on effects of He’s Sangma Xingbei Decoction on acute exacerbation of chronic obstructive pulmonary disease

YAO Liang; LI Jiayi; SHEN Yuanyuan; HE Xinhui

doi:10.16305/j.1007-1334.2018.02.012

您当前的位置：

首页 >

文章列表页 >

Clinical observation on effects of He’s Sangma Xingbei Decoction on acute exacerbation of chronic obstructive pulmonary disease

更新时间：2022-08-31

- Clinical observation on effects of He’s Sangma Xingbei Decoction on acute exacerbation of chronic obstructive pulmonary disease
- Shanghai Journal of Traditional Chinese Medicine Vol. 52, Issue 2, Pages: 51-54(2018)
- 作者机构：
  
  1. 上海中医药大学附属岳阳中西医结合医院呼吸内科,上海,200437
  2. 上海中医药大学基础医学院,上海,201203
- 作者简介：
- 基金信息：
- DOI：10.16305/j.1007-1334.2018.02.012
  CLC：
扫描看全文
YAO Liang, LI Jiayi, SHEN Yuanyuan, et al. Clinical observation on effects of He’s Sangma Xingbei Decoction on acute exacerbation of chronic obstructive pulmonary disease. [J]. Shanghai Journal of Traditional Chinese Medicine 52(2):51-54(2018)
DOI：

YAO Liang, LI Jiayi, SHEN Yuanyuan, et al. Clinical observation on effects of He’s Sangma Xingbei Decoction on acute exacerbation of chronic obstructive pulmonary disease. [J]. Shanghai Journal of Traditional Chinese Medicine 52(2):51-54(2018) DOI： 10.16305/j.1007-1334.2018.02.012.

摘要

目的：观察何氏桑麻杏贝汤联合西药治疗慢性阻塞性肺疾病急性加重期的临床疗效。方法：将60例慢性阻塞性肺疾病急性加重期患者随机分成治疗组和对照组,每组30例。对照组予西医常规治疗,治疗组予何氏桑麻杏贝汤加西医常规治疗。两组疗程均为14天,观察临床疗效,比较咳嗽症状总积分、内毒素鲎测定水平、肺功能及呼吸困难等级(mMRC等级)的变化情况。结果：①治疗组、对照组临床总有效率分别为93.3%、66.7%；组间临床疗效比较,治疗组明显优于对照组(P,<,0.05)。②组间治疗后比较,咳嗽症状总积分与FEV,1,(%)水平差异有统计学意义,治疗组改善程度明显优于对照组(P,<,0.05)。③治疗前后组内比较,两组内毒素鲎测定水平差异均有统计学意义(P,<,0.05)；组间治疗前后差值比较,内毒素鲎测定水平差异有统计学意义,治疗组降低幅度明显大于对照组(P,<,0.05)。④组间治疗后比较,mMRC等级变化差异有统计学意义,治疗组明显优于对照组(P,<,0.05)。结论：何氏桑麻杏贝汤联合西药治疗慢性阻塞性肺疾病急性加重期的疗效满意,可明显改善患者气流受限症状,有效抑制机体急性炎症反应,进而有助于尽快控制病情。

Abstract

Objective:To observe the clinical efficacy of He’s Sangma Xingbei Decoction combined with western medicine in the treatment of acute exacerbation of chronic obstructive pulmonary disease(AECOPD). Methods60 AECOPD patients randomly divided into the treatment group and control group,30 cases in each group. The control group was treated with the conventional therapy of western medicine,and the treatment group was treated with He’s Sangma Xingbei Decoction combined with the conventional therapy of western medicine,with a course of 14 days. The clinical efficacy was observed,and the changes on the total score of coughing symptom,level of limulus amebocyte lysate test,pulmonary function indexes and dyspnea grades in modified British Medical Research Council(mMRC)questionnaire were compared. Results:①The clinical total effective rates were 93.33% in the treatment group and 66.67% in the control group. The clinical efficacy of the treatment group was obviously better than that of the control group(P,<,0.05). ②After treatment,there were statistically significant differences on the total score of coughing symptom and level of FEV,1,(%)between the two groups,and the improvement in the treatment group was obviously better than that in the control group(P,<,0.05). ③In both groups,there was statistically significant difference on the level of limulus amebocyte lysate test between treatment before and after(P,<,0.05). For the D-value of level of limulus amebocyte lysate test between treatment before and after,there was statistically significant difference on the D-value between the two groups,and the D-value of the treatment group was greater than that of the control group(P,<,0.05). ④After treatment,there were statistically significant differences on the mMRC grades between the two groups,and the symptom improvement in the treatment group was obviously better than that in the control group(P,<,0.05). Conclusion:He’s Sangma Xingbei Decoction combined with western medicine shows good efficacy in the treatment of acute exacerbation of chronic obstructive pulmonary disease,which can obviously improve the symptoms of airflow limitation in patients,effectively inhibit the acute inflammatory response and then help to control the illness as soon as possible.

关键词

慢性阻塞性肺疾病急性加重期何氏桑麻杏贝汤炎症反应气流受限痰热蕴肺

Keywords

chronic obstructive pulmonary diseaseacute exacerbation stageHe’s Sangma Xingbei Decoctioninflammatory responseairflow limitationphlegm-heat stagnating in lung

references

Views

166

下载量

CSCD

CNKI被引量

Alert me when the article has been cited

提交

Tools

Publicity Resources

Distribution rule of TCM syndrome elements in chronic obstructive pulmonary disease with lung cancer

Regulatory mechanism of Xiaochuanning Granule on airway inflammation in rats with bronchial asthma

Effects and mechanism of Shugan Huatan Jiangzhi Decoction on reducing inflammatory injury in mice with non⁃alcoholic fatty liver disease

Research progress on relationship between skeletal muscle atrophy and apoptosis in COPD based on theory of “spleen dominating muscles” and intervention effect of traditional Chinese medicine

Research progress on mechanism of traditional Chinese medicine on pulmonary disease / hypoxia induced pulmonary hypertension

Related Author

No data

Related Institution

Suzhou Hospital of Traditional Chinese Medicine

Shanghai Pulmonary Hospital， Tongji University

Respiratory Department of Third Affiliated Hospital of Beijing University of Chinese Medicine

Shanghai Key Laboratory of Traditional Chinese Clinical Medicine

Key Laboratory of Liver and Kidney Diseases （Ministry of Education）

⁰